UBS Group’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Buy |
893,352
+362,449
| +68% | +$1.01M | ﹤0.01% | 3636 |
|
|
2025
Q1 | $1.91M | Buy |
530,903
+359,585
| +210% | +$1.29M | ﹤0.01% | 3730 |
|
|
2024
Q4 | $540K | Buy |
171,318
+138,772
| +426% | +$437K | ﹤0.01% | 4637 |
|
|
2024
Q3 | $91.8K | Sell |
32,546
-39,194
| -55% | -$111K | ﹤0.01% | 5236 |
|
|
2024
Q2 | $88.2K | Sell |
71,740
-170,752
| -70% | -$210K | ﹤0.01% | 5134 |
|
|
2024
Q1 | $193K | Buy |
242,492
+117,503
| +94% | +$93.3K | ﹤0.01% | 4739 |
|
|
2023
Q4 | $119K | Buy |
124,989
+72,420
| +138% | +$68.9K | ﹤0.01% | 4896 |
|
|
2023
Q3 | $56.8K | Buy |
52,569
+46,843
| +818% | +$50.6K | ﹤0.01% | 5090 |
|
|
2023
Q2 | $5.14K | Buy |
5,726
+2,226
| +64% | +$2K | ﹤0.01% | 6390 |
|
|
2023
Q1 | $2.96K | Sell |
3,500
-25,267
| -88% | -$21.4K | ﹤0.01% | 7311 |
|
|
2022
Q4 | $26.8K | Buy |
28,767
+25,098
| +684% | +$23.3K | ﹤0.01% | 6184 |
|
|
2022
Q3 | $6K | Sell |
3,669
-31,504
| -90% | -$51.5K | ﹤0.01% | 7904 |
|
|
2022
Q2 | $75K | Buy |
35,173
+22,914
| +187% | +$48.9K | ﹤0.01% | 4628 |
|
|
2022
Q1 | $44K | Buy |
12,259
+11,959
| +3,986% | +$42.9K | ﹤0.01% | 5597 |
|
|
2021
Q4 | $1K | Sell |
300
-8,321
| -97% | -$27.7K | ﹤0.01% | 8828 |
|
|
2021
Q3 | $64K | Sell |
8,621
-2,943
| -25% | -$21.8K | ﹤0.01% | 5043 |
|
|
2021
Q2 | $154K | Sell |
11,564
-13,381
| -54% | -$178K | ﹤0.01% | 4526 |
|
|
2021
Q1 | $189K | Sell |
24,945
-53,722
| -68% | -$407K | ﹤0.01% | 4559 |
|
|
2020
Q4 | $1.32M | Buy |
78,667
+74,367
| +1,729% | +$1.25M | ﹤0.01% | 2949 |
|
|
2020
Q3 | $54K | Hold |
4,300
| – | – | ﹤0.01% | 4742 |
|
|
2020
Q2 | $48K | Buy |
+4,300
| New | +$48K | ﹤0.01% | 5051 |
|